Significant response to immune checkpoint inhibitor camrelizumab in a heavily pretreated advanced ER+/HER2-breast cancer patient with high tumor mutational burden: a case report
user-5f8cf9244c775ec6fa691c99（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要